Pub. Date : 2012 Dec
PMID : 23000518
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Moreover, pan-caspase inhibitor z-VAD-fmk (zVAD) increased RIP1 expression and exacerbated TNFalpha-induced mitochondrial dysfunction and ROS production, indicating that RIP1 led to mitochondrial dysfunction and ROS production. | benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone | receptor (TNFRSF)-interacting serine-threonine kinase 1 | Mus musculus |
| 2 | Moreover, pan-caspase inhibitor z-VAD-fmk (zVAD) increased RIP1 expression and exacerbated TNFalpha-induced mitochondrial dysfunction and ROS production, indicating that RIP1 led to mitochondrial dysfunction and ROS production. | benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone | receptor (TNFRSF)-interacting serine-threonine kinase 1 | Mus musculus |
| 3 | Moreover, pan-caspase inhibitor z-VAD-fmk (zVAD) increased RIP1 expression and exacerbated TNFalpha-induced mitochondrial dysfunction and ROS production, indicating that RIP1 led to mitochondrial dysfunction and ROS production. | benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone | receptor (TNFRSF)-interacting serine-threonine kinase 1 | Mus musculus |
| 4 | Moreover, pan-caspase inhibitor z-VAD-fmk (zVAD) increased RIP1 expression and exacerbated TNFalpha-induced mitochondrial dysfunction and ROS production, indicating that RIP1 led to mitochondrial dysfunction and ROS production. | benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone | receptor (TNFRSF)-interacting serine-threonine kinase 1 | Mus musculus |